Canada Pension Plan Investment Board
PTLA

Canada Pension Plan Investment Board’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,745
Closed -$155K – 1525
2020
Q1 		$155K Buy
+21,745
New +$271K ﹤0.01% 1137
2019
Q4 		– Sell
-34,696
Closed -$931K – 1508
2019
Q3 		$931K Buy
+34,696
New +$974K ﹤0.01% 966
2019
Q1 		– Sell
-222,200
Closed -$4.34M – 1669
2018
Q4 		$4.34M Buy
222,200
+124,600
+128% +$2.56M 0.01% 808
2018
Q3 		$2.6M Buy
97,600
+50,900
+109% +$1.66M ﹤0.01% 974
2018
Q2 		$1.76M Sell
46,700
-5,800
-11% -$222K ﹤0.01% 992
2018
Q1 		$1.72M Buy
52,500
+11,800
+29% +$518K ﹤0.01% 999
2017
Q4 		$1.98M Buy
40,700
+37,400
+1,133% +$1.89M ﹤0.01% 883
2017
Q3 		$178K Buy
+3,300
New +$194K ﹤0.01% 1046

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Canada Pension Plan Investment Board's PTLA Position: Q2 2020 in Review

Canada Pension Plan Investment Board sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 21,745 shares — an estimated $155K sold.

Canada Pension Plan Investment Board first reported a position in PTLA in Q3 2017 and held it in 8 quarters. The position peaked at $4.34M in Q4 2018. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Canada Pension Plan Investment Board reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 21,745 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $155K.
  • Canada Pension Plan Investment Board first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
  • Canada Pension Plan Investment Board's Portola Pharmaceuticals, Inc. position peaked at $4.34M in Q4 2018.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2020, filed 14 Aug 2020.